Office of the Provost and Senior Vice-President

Projects

Projects per year 1995 2012 2013 2016 2017 2018 2019 2020 2021 2022 2023 2024 9999

• 184 Curtailed
• 479 Not started
• 3658 Active
• 19254 Finished

Projects per year

Search results

• Active

  Care and Repair: Rethinking Contemporary Curation for Conditions of Crisis

  McDowell, T. (Primary Chief Investigator (PCI)), Antoinette, M. (Chief Investigator (CI)), McQuilten, G. (Chief Investigator (CI)) & Khan, R. (Partner Investigator (PI))

  Australian Research Council (ARC)

  31/12/24 → 30/12/27

  Project: Research

• A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy

  Webber, K. (Primary Chief Investigator (PCI))

  23/12/24 → 22/12/29

  Project: Research

• Biochar production and properties for electric ironmaking

  Strezov, V. (Primary Chief Investigator (PCI)), Jiang, Y. (Chief Investigator (CI)), Evans, T. (Partner Investigator (PI)) & Ching, T. (Project Manager)

  20/12/24 → 20/12/29

  Project: Research

• A Phase 3 Randomized, Double-blind, 52-week Placebo Controlled Multi-center Study with a Double-blind 52-week Extension Period with Randomized Dose up/Dose down Titration Investigating the Efficacy, Safety, and Tolerability of Ritlecitinib in Adult Participants with Nonsegmental Vitiligo

  Kern, J. (Primary Chief Investigator (PCI))

  19/12/24 → 18/12/26

  Project: Research

• Foundations in Indigenous Disaster Resilience

  Williamson, B. (Primary Chief Investigator (PCI)), Reidy, N. (Chief Investigator (CI)), Connole, L. (Chief Investigator (CI)), Rogers, B. (Chief Investigator (CI)), Weir, J. (Chief Investigator (CI)), Gibbs, L. (Chief Investigator (CI)) & Quinn, P. (Chief Investigator (CI))

  Natural Hazards and Disaster Resilience Research Centre Limited (trading as Natural Hazards Research Australia)

  19/12/24 → 31/03/27

  Project: Research

• An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients with Focal Onset or Primary Generalized Tonic-Clonic Seizures

  O'Brien, T. (Primary Chief Investigator (PCI))

  18/12/24 → 17/12/26

  Project: Research

• A Phase 2 Randomized, Proof of Concept Study to Evaluate the Safety, Tolerability, and Efficacy of NGM120 in Pregnant Women with Severe Nausea and Vomiting (Hyperemesis Gravidarum)

  Palmer, K. (Primary Chief Investigator (PCI))

  18/12/24 → 17/12/29

  Project: Research

• A Phase 1b Study of JNJ-79635322 in Combination with Daratumumab or Pomalidomide for Multiple Myeloma

  Low, M. (Primary Chief Investigator (PCI))

  18/12/24 → 17/12/29

  Project: Research

• A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab in Patients with Chronic Spontaneous Urticaria Who Remain Symptomatic Despite H1 Antihistamine Treatment (EMBARQ – CSU2)

  Kern, J. (Primary Chief Investigator (PCI))

  18/12/24 → 18/12/26

  Project: Research

• GS-US-699-7184 A Phase 2 Platform Study of Novel Combination Therapies in Participants with Head and Neck Squamous Cell Carcinoma” and GS-US-699-7184 Substudy-01, VELOCITY-HNSCC Substudy-01 A Phase 2 Study of Novel Combination Therapies in Participants With Previously Untreated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status

  Alamgeer, M. (Primary Chief Investigator (PCI))

  18/12/24 → 17/12/29

  Project: Research

• Artificial Intelligence.: Augmenting the Debrief of Emergency Resuscitation In-situ Simulation utilising Artificial Intelligence.

  Martinez-Maldonado, R. (Primary Chief Investigator (PCI)), Connell, C. (Chief Investigator (CI)), Echeverria, V. (Chief Investigator (CI)), Chen, G. (Chief Investigator (CI)), Sevenhuysen, S. L. (Chief Investigator (CI)) & Davis, J. (Chief Investigator (CI))

  18/12/24 → 18/12/27

  Project: Research

• Engaged Classrooms through Effective Classroom Management

  Fox, R. (Primary Chief Investigator (PCI)) & Leif, E. (Chief Investigator (CI))

  18/12/24 → 19/12/26

  Project: Research

• A Phase 1, open label single-arm two-part study to investigate safety, pharmacokinetics, and preliminary efficacy of pan-RAF/MEK glue NST-628 oral tablets in subjects with solid tumors harboring genetic alterations in the MAPK pathway and with other solid tumors

  Bhave, P. (Primary Chief Investigator (PCI))

  17/12/24 → 17/12/26

  Project: Research

• Corrosion triggered self-passivation of magnesium alloys

  Chen, X. (Primary Chief Investigator (PCI)), Zhu, Y. (Chief Investigator (CI)), Mol, A. (Partner Investigator (PI)), Frankel, G. (Partner Investigator (PI)) & Keil, P. (Partner Investigator (PI))

  16/12/24 → 15/12/27

  Project: Research

• Treatment Of early gestational diabetes Mellitus: THe follow-Up of Mothers and Babies future cardio-metabolic risk and neurodevelopment (TOMTHUMB)

  Simmons, D. S. (Primary Chief Investigator (PCI)), Cheung, N. W. (Chief Investigator (CI)), Nolan, C. (Chief Investigator (CI)), Teede, H. (Chief Investigator (CI)), Sweeting, A. (Chief Investigator (CI)), Craig, M. E. (Chief Investigator (CI)), Enticott, J. (Chief Investigator (CI)), Tannous, W. (Chief Investigator (CI)), Joglekar, M. V. (Chief Investigator (CI)), Hague, W. M. (Chief Investigator (CI)), Hibbert, E. J. (Associate Investigator (AI)), Gianatti, E. J. (Associate Investigator (AI)), Wong, V. W. M. (Associate Investigator (AI)), Wong, T. (Associate Investigator (AI)), Hicks, R. (Associate Investigator (AI)), Williams, K. (Associate Investigator (AI)), Peek, M. J. (Associate Investigator (AI)), MacMillan, F. (Associate Investigator (AI)) & Duke, A. (Associate Investigator (AI))

  16/12/24 → 30/06/29

  Project: Research

• Educator-child interactions and childhood social and emotional learning

  Blewitt, C. (Primary Chief Investigator (PCI)), Skouteris, H. (Chief Investigator (CI)), Edwards, S. (Chief Investigator (CI)), Morris, H. (Chief Investigator (CI)) & Kirk, H. (Chief Investigator (CI))

  Australian Research Council (ARC)

  15/12/24 → 14/12/27

  Project: Research

• Dynamic Single-Atom Liquid Metal Nanozymes

  Rahim, M. A. (Primary Chief Investigator (PCI))

  Monash University – Internal Faculty Contribution

  15/12/24 → 14/12/28

  Project: Research

• Developing a Global Air Quality Alert and Forecast System

  Guo, Y. (Primary Chief Investigator (PCI)), Yu, A. (Chief Investigator (CI)), Li, S. (Chief Investigator (CI)), Xu, R. (Chief Investigator (CI)) & Liu, L. (Chief Investigator (CI))

  13/12/24 → 31/12/25

  Project: Research

• Workstream 2.4: Harnessing of Technology for VAW Prevention

  Flynn, A. (Primary Chief Investigator (PCI)), Carlson, B. (Chief Investigator (CI)), O'Leary, P. (Chief Investigator (CI)), Eddyono, S. (Partner Investigator (PI)), Amin, S. (Partner Investigator (PI)), Powell, A. (Associate Investigator (AI)) & Kennedy, T. (Associate Investigator (AI))

  13/12/24 → 13/12/27

  Project: Research

• A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV 7000 in Subjects with Refractory Focal Onset Epilepsy

  O'Brien, T. (Primary Chief Investigator (PCI))

  10/12/24 → 10/12/26

  Project: Research

• Abbvie MRDR Support

  Wood, E. (Primary Chief Investigator (PCI)), McQuilten, Z. (Chief Investigator (CI)) & Moore, E. (Chief Investigator (CI))

  9/12/24 → 8/12/25

  Project: Research

• Deep Learning Theory

  Wei, S. (Primary Chief Investigator (PCI))

  Google (Singapore)

  9/12/24 → …

  Project: Research

• A randomized, double-blind, double-dummy, placebo-controlled, multicenter, Phase 3 study assessing the efficacy, safety, and tolerability of 2 doses of remibrutinib over a 68-week treatment period in adult patients with moderate to severe hidradenitis suppurativa

  Kern, J. (Primary Chief Investigator (PCI)), Fernandez-Penas, P. (Chief Investigator (CI)), Nicolopoulos, J. (Chief Investigator (CI)) & Wong, C. (Chief Investigator (CI))

  9/12/24 → 9/12/27

  Project: Research

• A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Crohn’s Disease

  Moore, G. (Primary Chief Investigator (PCI))

  9/12/24 → 8/12/29

  Project: Research

• A Phase 3, Randomized, Double-blind, Active-Comparator-Controlled Clinical Study to Evaluate the Efficacy and Safety of Bomedemstat (MK- 3543) versus Hydroxyurea in Cytoreductive Therapy Naïve Essential Thrombocythemia Participants

  Yeh, P. (Primary Chief Investigator (PCI))

  9/12/24 → 8/12/29

  Project: Research

• A Phase 2, Multicenter, Single-blinded, Randomized Study to Evaluate the Pharmacokinetics and Safety of Sotatercept (MK-7962) Administered Using Either a Weight-based or Weight-banded Approach in Participants With Pulmonary Arterial Hypertension (PAH) on Standard of Care

  Yo, S. (Primary Chief Investigator (PCI))

  9/12/24 → 8/12/26

  Project: Research

• Long Foundation Fellowship

  Ooi, J. (Primary Chief Investigator (PCI))

  8/12/24 → 4/02/28

  Project: Research

• MAGNITUDE: A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM)

  Hare, J. (Primary Chief Investigator (PCI))

  7/12/24 → 6/12/26

  Project: Research

• SFL: Scenarios for Future Living: Putting People at the Centre of the Energy Transition

  Strengers, Y. (Primary Chief Investigator (PCI)), Pink, S. (Chief Investigator (CI)), Ben-David, R. (Chief Investigator (CI)), MacGill, I. (Chief Investigator (CI)), Roberts, M. (Chief Investigator (CI)), Bruce, A. (Chief Investigator (CI)), Passey, R. (Chief Investigator (CI)), McConnell , D. (Chief Investigator (CI)), Mellick Lopes, A. (Chief Investigator (CI)), Tonkinwise, C. (Chief Investigator (CI)), Briggs, C. (Chief Investigator (CI)), Riedy, C. (Chief Investigator (CI)), Kaviani, F. (Chief Investigator (CI)), Dahlgren, K. (Chief Investigator (CI)) & Lipscombe, S. (Project Manager)

  6/12/24 → 6/12/27

  Project: Research

• An Open-Label Phase 2 Study to Evaluate the Efficacy, Safety and Tolerability of BMB-101 in Adults with either classic Absence Epilepsy (with or without Eyelid Myoclonia (EEM; Jeavons syndrome), OR Developmental Epileptic Encephalopathy (DEE)

  O'Brien, T. (Primary Chief Investigator (PCI)), Zentner, C. (Chief Investigator (CI)), Reutens, D. C. (Chief Investigator (CI)) & Scheffer, I. E. (Chief Investigator (CI))

  5/12/24 → 5/12/26

  Project: Research

• Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Kapoor, M. (Primary Chief Investigator (PCI))

  5/12/24 → 4/12/26

  Project: Research

• An Interventional, Open-Label, Randomized, Multicenter Phase 2 Study of PF-07220060 Plus Letrozole Compared to Letrozole Alone in Postmenopausal Women 18 Years or Older With Hormone Receptor-Positive, HER2-Negative Breast Cancer in the Neoadjuvant Setting

  Muttiah, C. (Primary Chief Investigator (PCI))

  5/12/24 → 5/12/26

  Project: Research

• Review of Rail Condition and Rail Grinding Cycles

  Ravitharan, S. (Primary Chief Investigator (PCI)) & Lambert, R. (Chief Investigator (CI))

  4/12/24 → 31/10/25

  Project: Research

• Upgrading rare earth minerals and elements using computer-aided collector design

  Page, A. (Primary Chief Investigator (PCI)), Thang, S. H. (Chief Investigator (CI)), Skinner , B. (Chief Investigator (CI)), Zhao , C.-X. (Chief Investigator (CI)) & Galvin, K. P. (Chief Investigator (CI))

  4/12/24 → 31/12/28

  Project: Research

• Development of stimuli responsive Bio and RAFT polymers

  Ritchie, C. (Primary Chief Investigator (PCI)), Thang, S. H. (Chief Investigator (CI)), Zhao , C.-X. (Chief Investigator (CI)), Franks, G. V. (Chief Investigator (CI)) & Ata, S. (Chief Investigator (CI))

  4/12/24 → 31/12/26

  Project: Research

• A randomized, phase 3, open-label study to evaluate SGN-B6A compared with docetaxel in adult subjects with previously treated non-small cell lung cancer

  Moore, M. (Primary Chief Investigator (PCI))

  4/12/24 → 3/12/26

  Project: Research

• Workstream 2.1: Spirituality and Institutions of Religion: Community Effects on VAW

  Wendt, S. (Primary Chief Investigator (PCI)), Davies, S. E. (Chief Investigator (CI)), Humphreys, C. F. (Chief Investigator (CI)), Cripps, K. (Chief Investigator (CI)) & Vaughan, C. (Associate Investigator (AI))

  3/12/24 → 3/12/27

  Project: Research

• A Phase 3, randomized, double-blind, placebo-controlled, parallelgroup, 3-arm, multinational, multicenter study to evaluate the efficacy and safety of amlitelimab by subcutaneous injection in participants aged 12 years and older with moderate-to-severe atopic dermatitis (AD) who are on background topical corticosteroids and have had an inadequate response to prior biologic therapy or oral Janus Kinase (JAK) inhibitor treatment

  Kern, J. (Primary Chief Investigator (PCI))

  2/12/24 → 1/12/26

  Project: Research

• A Phase 1 Study of Pre-Operative Cemiplimab (REGN2810), Administered Intralesionally, for Patients with Cutaneous Squamous Cell Carcinoma (CSCC) or Basal Cell Carcinoma (BCC)

  Kern, J. (Primary Chief Investigator (PCI))

  2/12/24 → 2/12/26

  Project: Research

• Strategies for implementing alternative land tenure and use models in Australia to address the housing crisis

  Alexander, J. & Murray, C.

  Trustee for the Alastair Swayn Foundation

  1/12/24 → 1/12/25

  Project: Research

• Controllable quantum phases in two-dimensional metal-organic nanomaterials

  Schiffrin, A. (Primary Chief Investigator (PCI)), MacLeod, J. (Chief Investigator (CI)), Jelinek, P. (Partner Investigator (PI)) & Bhattacharyya, S. (Partner Investigator (PI))

  1/12/24 → 30/11/27

  Project: Research

• Improving mental health and wellbeing in diverse children with disruptive disorders: A co-designed school-based early intervention involving parent-teacher collaboration

  Kimonis, E. R. (Primary Chief Investigator (PCI)), Goulter, N. (Chief Investigator (CI)), Fleming, G. (Chief Investigator (CI)), Taylor, N. J. (Chief Investigator (CI)), Mihalopoulos, C. (Chief Investigator (CI)), Briggs, N. E. (Associate Investigator (AI)), Hawes, D. (Associate Investigator (AI)), Dadds, M. R. (Associate Investigator (AI)) & Nickerson, A. (Associate Investigator (AI))

  1/12/24 → 30/11/26

  Project: Research

• Cardiovascular Disease (CVD) perception and knowledge among adolescents across two continents: Africa and Australia

  Akombi, B. (Primary Chief Investigator (PCI)), Schutte, A. (Chief Investigator (CI)), Byaruhanga, J. (Chief Investigator (CI)), Nattabi, B. (Chief Investigator (CI)), Kalu, K. (Chief Investigator (CI)), Bello, A. (Chief Investigator (CI)), Namanda, C. (Chief Investigator (CI)), Badlangana, L. (Partner Investigator (PI)), Phegelo, M. (Partner Investigator (PI)), Adjabu, D. (Chief Investigator (CI)), Matlhagela , K. (Partner Investigator (PI)), Kilkenny, M. (Chief Investigator (CI)), Olaiya, M. (Chief Investigator (CI)), Odunaiya, N. (Chief Investigator (CI)) & Adebayo, B. (Chief Investigator (CI))

  1/12/24 → 31/12/25

  Project: Research

• Development of Radiation Therapy Advanced Practice Capabilities

  Wright, C. & Matthews, K.

  1/12/24 → 31/03/26

  Project: Research

• Q168: Evidence generation for side effect burden item Q168

  Nolte, S. (Chief Investigator (CI))

  1/12/24 → 31/05/27

  Project: Research

• A novel treatment to spare insulin and improve glucose control

  Cowley, M. (Primary Chief Investigator (PCI)), Simonds, S. (Chief Investigator (CI)), Pollock, C. (Chief Investigator (CI)), Chen, X.-M. (Chief Investigator (CI)) & Cooke, I. (Associate Investigator (AI))

  1/12/24 → 30/11/25

  Project: Research

• SPIA Country Study, North India - THE DYNAMICS OF AGRICULTURAL INNOVATION IN NORTH INDIA

  Datt, G. (Primary Chief Investigator (PCI)), Swaminathan, M. (Chief Investigator (CI)), Tjernstrom, E. (Chief Investigator (CI)), Baksi, S. (Chief Investigator (CI)), Jacob, S. (Partner Investigator (PI)) & Jolliffe, D. (Partner Investigator (PI))

  1/12/24 → 30/11/27

  Project: Research

• The project focuses on the Yiddish poetry of Abraham Sutskever (1913-2010), widely considered the greatest of the Yiddish poets.

  Wolski, N. (Primary Chief Investigator (PCI))

  30/11/24 → 30/11/26

  Project: Research

• Supporting children’s mathematics transition to primary school in play

  Li, L. (Primary Chief Investigator (PCI)), Disney, L. (Chief Investigator (CI)) & Downton, A. (Chief Investigator (CI))

  Collier Charitable Fund

  30/11/24 → 30/11/25

  Project: Research

• A First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Advanced Solid Tumor Patients and in Combination With Fulvestrant in Patients With Advanced Breast Cancer

  Moore, M. (Primary Chief Investigator (PCI))

  29/11/24 → 29/11/26

  Project: Research